Submitted by Anonymous (not verified) on 5 November 2026 - 13:06
Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, Date of authorisation: 24/09/2020, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, Date of authorisation: 24/09/2020, Revision: 15, Status: Authorised